PLoS ONE · 2018 · 18 citations · 28 references
MedicineNeurobiologyNeuroscienceCell TherapyRegenerative MedicineStem Cell TransplantationAcute Ischemic StrokeHypoxic-ischemic Brain InjuryMesenchymal Stem Cell TherapyNeural Stem Cell BiologyNeural Stem CellsNeuroprotectionBone Marrow Mesenchymal Stem CellsCerebral Ischemia NeuroprotectionCombination Cell TherapyHypothermiaHypothermia TreatmentNeuroprotective MechanismsRodent Cerebral IschemiaTransplantation
Bone marrow mesenchymal stem cells (BMSCs) are used as a great promising choice for the treatment of cerebral ischemia. Herein, we discuss the neuroprotective effects of the combination of BMSCs transplantation and mild hypothermia (MH) in an ischemia-reperfusion rat model. First, BMSCs were isolated using density gradient centrifugation and the adherent screening method, followed by culture, identification and labeling with DAPI. Second, adult male SD rats were divided into 5 groups: sham group (surgery without blockage of middle cerebral artery), model group (middle cerebral artery occlusion (MCAO) was established 2h prior to reperfusion), BMSCs group (injection of BMSCs via the lateral ventricle 24h after MCAO), MH group (mild hypothermia for 3h immediately after MCAO) and combination therapy group (combination of BMSCs and MH). Finally, the modified neurological severity score (mNSS) test was performed to assess behavioral function at different time points (before MCAO, before transplantation, at day 1, day 5 and day 10 after transplantation). After that, the brain was subjected to TTC staining, and the homing and angiogenesis were evaluated by immumofluorescence and immunohistochemistry. Immunofluorescence staining and Western Blot analysis were performed to calculate the percentage of the infarct area and explore glial fibrillary acidic protein (GFAP) and vascular endothelial growth factor (VEGF). Our results showed that the combination therapy significantly decreased mNSS scores (P<0.01) and reduced the percentage of the infarct area (P<0.01) than a single treatment. Moreover, the expression of GFAP and VEGF increased significantly in the combination therapy group (at day 5, day 10 after transplantation; at all time points after transplantation, respectively) compared to the single treatment groups. Taken together, it was suggested that the combination of BMSCs transplantation and MH can significantly reduce the percentage of the infarct area and improve functional recovery by promoting homing and angiogenesis, which may be a beneficial treatment for cerebral ischemia.
28
Reversible middle cerebral artery occlusion without craniectomy in rats.
Enrique Zea Longa, Philip R. Weinstein, Shaun W. Carlson et al. · Stroke · 1989 · 7.5K citations · Full text
Medicine, Neuroscience, Surgery +17
Gene Kopen, Darwin J. Prockop, Donald G. Phinney · Proceedings of the National Academy of Sciences · 1999 · 1.6K citations
Moderate Hypothermia in the Treatment of Patients With Severe Middle Cerebral Artery Infarction
Stefan Schwab, S. Schwarz, Matthias Spranger et al. · Stroke · 1998 · 677 citations · Full text
Medicine, Neurology, Neuroscience +17
Ischemic rat brain extracts induce human marrow stromal cell growth factor production
Xiaoguang Chen, Yi Li, Lei Wang et al. · Neuropathology · 2002 · 385 citations
Medicine, Neurobiology, Neuroscience +17